Alkeus Pharmaceuticals
Latest round
- Series B
Last raised
- Jun 2023
Total raised
- $150M
Investors
- 4
About Alkeus Pharmaceuticals
Based in Massachusetts, US, and founded in 2010 by President and Chief Executive Officer Leonide Saad and co-founders Ilyas Washington, Alkeus Pharmaceuticals Inc. operates as a biotechnology company providing treatment of degenerative eye diseases for patients. In June 2023, Alkeus Pharmaceuticals Inc. Alkeus Pharmaceuticals Inc. provides treatment of Stargardt disease of the eye known as Gildeuretinol (ALK-001), which is a medicine in clinical development to selectively address the underlying mechanism of Stargardt disease, by reducing the rate of vitamin A dimerization in the eye. The company offers therapy for genetic and autosomal recessive diseases.
Who invested in Alkeus Pharmaceuticals
4 investors across 1 round
See all investors in Alkeus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 5, 2023
Amount
$150M
Investors
Questions about Alkeus Pharmaceuticals
Who invested in Alkeus Pharmaceuticals?
Alkeus Pharmaceuticals has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alkeus Pharmaceuticals raised?
Alkeus Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alkeus Pharmaceuticals last raise money?
Alkeus Pharmaceuticals's most recent round on record is a Series B, in Jun 2023.
What does Alkeus Pharmaceuticals do?
Based in Massachusetts, US, and founded in 2010 by President and Chief Executive Officer Leonide Saad and co-founders Ilyas Washington, Alkeus Pharmaceuticals Inc.
Where is Alkeus Pharmaceuticals headquartered?
Alkeus Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Alkeus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alkeus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Alkeus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.